Amgen agrees to acquire Horizon Therapeutics in $27.8bn deal
The acquisition will add several approved drugs into Amgen’s portfolio, along with potential new medicines from Horizon’s R&D pipeline.
Read more: Amgen agrees to acquire Horizon Therapeutics in $27.8bn deal
